Literature DB >> 19433254

Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life.

Erin P Hines1, Sally S White, Jason P Stanko, Eugene A Gibbs-Flournoy, Christopher Lau, Suzanne E Fenton.   

Abstract

The synthetic surfactant, perfluorooctanoic acid (PFOA) is a proven developmental toxicant in mice, causing pregnancy loss, increased neonatal mortality, delayed eye opening, and abnormal mammary gland growth in animals exposed during fetal life. PFOA is found in the sera and tissues of wildlife and humans throughout the world, but is especially high in the sera of children compared to adults. These studies in CD-1 mice aim to determine the latent health effects of PFOA following: (1) an in utero exposure, (2) an in utero exposure followed by ovariectomy (ovx), or (3) exposure as an adult. Mice were exposed to 0, 0.01, 0.1, 0.3, 1, 3, or 5mg PFOA/kg BW for 17 days of pregnancy or as young adults. Body weight was reduced in the highest doses on postnatal day (PND) 1 and at weaning. However, the lowest exposures (0.01-0.3mg/kg) significantly increased body weight, and serum insulin and leptin (0.01-0.1mg/kg) in mid-life after developmental exposure. PFOA exposure combined with ovx caused no additional increase in mid-life body weight. At 18 months of age, the effects of in utero PFOA exposure on body weight were no longer detected. White adipose tissue and spleen weights were decreased at high doses of PFOA in intact developmentally exposed mice, and spleen weight was reduced in PFOA-exposed ovx mice. Brown adipose tissue weight was significantly increased in both ovx and intact mice at high PFOA doses. Liver weight was unaffected in late life by these exposure paradigms. Finally, there was no effect of adult exposure to PFOA on body weight. These studies demonstrate an important window of exposure for low-dose effects of PFOA on body weight gain, as well as leptin and insulin concentrations in mid-life, at a lowest observed effect level of 0.01mg PFOA/kg BW. The mode of action of these effects and its relevance to human health remain to be explored.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19433254     DOI: 10.1016/j.mce.2009.02.021

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  102 in total

1.  Perfluorooctanoic Acid (PFOA)-induced Liver Lesions in Two Strains of Mice Following Developmental Exposures: PPARα Is Not Required.

Authors:  Adam J Filgo; Erin M Quist; Mark J Hoenerhoff; Amy E Brix; Grace E Kissling; Suzanne E Fenton
Journal:  Toxicol Pathol       Date:  2014-11-14       Impact factor: 1.902

Review 2.  Association of endocrine disruptors and obesity: perspectives from epidemiological studies.

Authors:  E E Hatch; J W Nelson; R W Stahlhut; T F Webster
Journal:  Int J Androl       Date:  2010-01-22

3.  Early-life exposures to persistent organic pollutants in relation to overweight in preschool children.

Authors:  Martina Karlsen; Philippe Grandjean; Pal Weihe; Ulrike Steuerwald; Youssef Oulhote; Damaskini Valvi
Journal:  Reprod Toxicol       Date:  2016-08-03       Impact factor: 3.143

4.  Prenatal perfluorooctanoic acid exposure in CD-1 mice: low-dose developmental effects and internal dosimetry.

Authors:  Madisa B Macon; LaTonya R Villanueva; Katoria Tatum-Gibbs; Robert D Zehr; Mark J Strynar; Jason P Stanko; Sally S White; Laurence Helfant; Suzanne E Fenton
Journal:  Toxicol Sci       Date:  2011-04-11       Impact factor: 4.849

Review 5.  Effects of Environmental Exposures on Fetal and Childhood Growth Trajectories.

Authors:  Tongzhang Zheng; Jie Zhang; Kathryn Sommer; Bryan A Bassig; Xichi Zhang; Jospeh Braun; Shuangqing Xu; Peter Boyle; Bin Zhang; Kunchong Shi; Stephen Buka; Siming Liu; Yuanyuan Li; Zengmin Qian; Min Dai; Megan Romano; Aifen Zou; Karl Kelsey
Journal:  Ann Glob Health       Date:  2016 Jan-Feb       Impact factor: 2.462

Review 6.  Endocrine disruptors and obesity.

Authors:  Jerrold J Heindel; Retha Newbold; Thaddeus T Schug
Journal:  Nat Rev Endocrinol       Date:  2015-09-22       Impact factor: 43.330

Review 7.  Polluted Pathways: Mechanisms of Metabolic Disruption by Endocrine Disrupting Chemicals.

Authors:  Mizuho S Mimoto; Angel Nadal; Robert M Sargis
Journal:  Curr Environ Health Rep       Date:  2017-06

8.  Fluorinated Compounds in U.S. Fast Food Packaging.

Authors:  Laurel A Schaider; Simona A Balan; Arlene Blum; David Q Andrews; Mark J Strynar; Margaret E Dickinson; David M Lunderberg; Johnsie R Lang; Graham F Peaslee
Journal:  Environ Sci Technol Lett       Date:  2017

9.  Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population.

Authors:  Jessica W Nelson; Elizabeth E Hatch; Thomas F Webster
Journal:  Environ Health Perspect       Date:  2010-02       Impact factor: 9.031

10.  PPARα in Obesity: Sex Difference and Estrogen Involvement.

Authors:  Michung Yoon
Journal:  PPAR Res       Date:  2010-08-17       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.